NCT06413056View on ClinicalTrials.gov

Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

May 20, 2023

Study Completion Date

August 30, 2023

Conditions
Neonatal InfectionInvasive Fungal Infections
Interventions
DRUG

Micafungin

Preterm neonate with fungal infection provened by fungal culture and who received fluconazole for at least one week will be divided into two groups. Will receive either micafungin or amphotericin B

DRUG

Amphotericin B

Preterm neonate with fungal infection provened by fungal culture and who received fluconazole for at least one week will be divided into two groups.

Trial Locations (1)

Unknown

Ain Shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER